The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Exceptional responders to abexinostat (ABX) plus pazopanib (PAZ) in pretreated renal cell carcinoma (RCC) and other solid tumors: Long-term follow-up of a phase 1b study.
 
Rahul Raj Aggarwal
Consulting or Advisory Role - AstraZeneca; Janssen
Research Funding - Abbvie; Cancer Targeted Technology; Gilead Sciences; Janssen; Merck; Novartis; Xynomic Pharma; Zenith Epigenetics
Travel, Accommodations, Expenses - Xynomic Pharma
 
Scott Thomas
No Relationships to Disclose
 
Nela Pawlowska
Employment - Allergan (I)
Travel, Accommodations, Expenses - Allergan (I)
 
Jennifer A. Grabowsky
No Relationships to Disclose
 
Susan Calabrese
No Relationships to Disclose
 
Phu Lam
No Relationships to Disclose
 
Kathleen Comerford
No Relationships to Disclose
 
Daphne Bautista
No Relationships to Disclose
 
Pamela N. Munster
Stock and Other Ownership Interests - OncoSec (I)
Honoraria - Amgen (I); Prometheus (I); Threshold Pharmaceuticals
Consulting or Advisory Role - HUYA Bioscience International
Research Funding - Andes Biotechnologies (Inst); Biomarin (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Immune Design (Inst); Intellikine (Inst); Merck (Inst); Merrimack (Inst); Nektar (Inst); Novartis (Inst); OncoMed (Inst); Onconova Therapeutics (Inst); oncosec (Inst); Pfizer (Inst); Piramal Life Science (Inst); Plexxikon (Inst); Sanofi (Inst)